Show simple item record

dc.contributor.authorKorf, Bruce
dc.contributor.authorAhmadian, Reza
dc.contributor.authorAllanson, Judith
dc.contributor.authorAoki, Yoko
dc.contributor.authorBakker, Annette
dc.contributor.authorWright, Emma Burkitt
dc.contributor.authorDenger, Brian
dc.contributor.authorElgersma, Ype
dc.contributor.authorGelb, Bruce D.
dc.contributor.authorGripp, Karen W.
dc.contributor.authorKerr, Bronwyn
dc.contributor.authorKontaridis, Maria Irene
dc.contributor.authorLazaro, Conxi
dc.contributor.authorLinardic, Corinne
dc.contributor.authorLozano, Reymundo
dc.contributor.authorMacRae, Calum Archibald
dc.contributor.authorMessiaen, Ludwine
dc.contributor.authorMulero-Navarro, Sonia
dc.contributor.authorNeel, Benjamin
dc.contributor.authorPlotkin, Scott Randall
dc.contributor.authorRauen, Katherine A.
dc.contributor.authorRoberts, Amy Elizabeth
dc.contributor.authorSilva, Alcino J.
dc.contributor.authorSittampalam, Sitta G.
dc.contributor.authorZhang, Chao
dc.contributor.authorSchoyer, Lisa
dc.date.accessioned2017-02-09T15:30:57Z
dc.date.issued2015
dc.identifier.citationKorf, Bruce, Reza Ahmadian, Judith Allanson, Yoko Aoki, Annette Bakker, Emma Burkitt Wright, Brian Denger, et al. 2015. The Third International Meeting on Genetic Disorders in the RAS/MAPK Pathway: Towards a Therapeutic Approach. American Journal of Medical Genetics Part A 167, no. 8: 1741–1746. Portico. doi:10.1002/ajmg.a.37089.en_US
dc.identifier.issn1552-4825en_US
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:30207916
dc.description.abstract"The Third International Meeting on Genetic Disorders in the RAS/MAPK Pathway: Towards a Therapeutic Approach" was held at the Renaissance Orlando at SeaWorld Hotel (August 2-4, 2013). Seventy-one physicians and scientists attended the meeting, and parallel meetings were held by patient advocacy groups (CFC International, Costello Syndrome Family Network, NF Network and Noonan Syndrome Foundation). Parent and patient advocates opened the meeting with a panel discussion to set the stage regarding their hopes and expectations for therapeutic advances. In keeping with the theme on therapeutic development, the sessions followed a progression from description of the phenotype and definition of therapeutic endpoints, to definition of genomic changes, to identification of therapeutic targets in the RAS/MAPK pathway, to preclinical drug development and testing, to clinical trials. These proceedings will review the major points of discussion.en_US
dc.language.isoen_USen_US
dc.publisherWiley-Blackwellen_US
dc.relation.isversionofdoi:10.1002/ajmg.a.37089en_US
dc.relation.hasversionhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515140/en_US
dash.licenseOAP
dc.subjectrasen_US
dc.subjectneurofibromatosisen_US
dc.subjectnoonan syndromeen_US
dc.subjectcostello syndromeen_US
dc.subjectcardio-facio-cutaneous syndromeen_US
dc.titleThe third international meeting on genetic disorders in the RAS/MAPK pathway: Towards a therapeutic approachen_US
dc.typeJournal Articleen_US
dc.description.versionAccepted Manuscripten_US
dc.relation.journalAmerican Journal of Medical Genetics Part Aen_US
dash.depositing.authorKontaridis, Maria Irene
dc.date.available2017-02-09T15:30:57Z
dc.identifier.doi10.1002/ajmg.a.37089*
dash.authorsorderedfalse
dash.contributor.affiliatedMacRae, Calum
dash.contributor.affiliatedRoberts, Amy
dash.contributor.affiliatedKontaridis, Maria
dash.contributor.affiliatedPlotkin, Scott


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record